Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Epidural steroid injections within a multimodal treatment concept for chronic non-radicular low back pain
2005-000787-90Phase 3Active
- Sponsor
- Sana-Klinik Sommerfeld
- Start
- May 2006
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised trial of triamcinolone acetonide in chronic low back pain (CLBP) and lumbar disc disease (2 arms), sponsored by Sana-Klinik Sommerfeld. Primary endpoints: Functional treatability and Change in functional status (SDS functional axis). Started May 2006; status: active.
02
Drugs
triamcinolone acetonide
03
Conditions
chronic low back pain (CLBP)lumbar disc disease
Beyond the preview
Go deeper on 2005-000787-90.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2005-000787-90.